Investors are increasingly embracing the recovery. We laid out our bullish 12 month view in our 2021 Outlook (Show Me the Money!) and spent last week talking with investors around the globe. Our call for higher earnings to drive returns seemed mostly consensus and we received little push back on our call for multiples to normalize lower. Vaccine efficacy has…
Stocks inched higher this past trading week, digesting a slew of updates that suggest the global and domestic economic...
It’s not just that Fitbit (FIT) reported a miss on the top-line, but more so that the company lowered...
The summer doldrums are here, or are they. Last Friday’s market action or reaction to some minor headlines shook...
A 3-week winning streak for equities came to an end for the S&P 500 (SPX) this past week. April...
The S&P 500 (SPX) deviated from a decade-long streak of underperformance during the Memorial Day trading week this past...
Cross-Asset Strategy: While growth risks are elevated, our base case looks for an acceleration in global growth in the...
By Merrill Lynch Macro Strategy—Deep Credit Restraint Likely In The Pipeline: Rapid-fire Federal Reserve (Fed) interest rate hikes...
The non-seasonally adjusted headline CPI eased for an eighth consecutive month to 6.0% in February (Chart 1). The seasonally...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
